Funding Received
$26.5 Million in 2 Rounds from 8 Investors
Most Recent Funding
$22 Million Series B on June 2, 2008
Headquarters:
Burnaby, BC
Description:
Inimex Pharmaceuticals is a clinical-stage company focused on the development and commercialization of innate defense regulators.
Categories:
Biotechnology
Website:
http://www.inimexpharma.com

Detailed Description

Update

Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body's innate defenses without causing inflammation.

Past Team (4)

Update

Board Members and Advisors (1)

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • Office

    8540 Baxter Place

    British Columbia,

    Burnaby, BC V5A 4T8

    CAN

News (2)

Update

Images (1)

Update
  • B94dba4c837d98b6d41f790a8b702615